GA
NVCR icon

GoalVest Advisory’s NovoCure NVCR Stock Holding History

GoalVest Advisory’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.09K Buy
+507
New +$8.46K ﹤0.01% 479

Other funds holding NVCR

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GoalVest Advisory's NVCR Position: Q3 2026 in Review

GoalVest Advisory opened a new position in NovoCure (NVCR) in Q3 2026: 507 shares worth $8.09K. The stake represents ﹤0.01% of the portfolio and ranks #479 among its holdings.

15 funds tracked by Wall St. Rank hold NVCR as of Q3 2026.

  • GoalVest Advisory held 507 shares of NovoCure worth $8.09K as of Q3 2026.
  • NovoCure was a new GoalVest Advisory position in Q3 2026.
  • NovoCure made up ﹤0.01% of GoalVest Advisory's portfolio in Q3 2026, its #479 holding.
  • 15 funds tracked by Wall St. Rank held NovoCure as of Q3 2026.

Based on GoalVest Advisory's 13F filing for Q3 2026, filed 2 Oct 2026.